1. The Start - Strategic Definition

Every SAGEIQ engagement begins with a detailed definition of the client’s strategic objectives.

This includes a structured analysis of:

• therapeutic area focus
• asset or technology characteristics
• development stage
• commercial positioning
• geographic rights availability
• potential partnering structures

These parameters establish the precise search criteria that guide the SAGEIQ analytical process.

​

2. Global Data Intelligence

The SAGENT™ engine conducts a deep analytical search across multiple layers of global life sciences intelligence. These may include:

• scientific and clinical development databases
• biotechnology and pharmaceutical pipelines
• licensing and transaction histories
• patent and intellectual property landscapes
• corporate strategy signals
• competitive positioning

​By integrating structured and unstructured data sources, SAGEIQ generates a comprehensive map of the relevant global opportunity landscape.

​

3. AI-Driven Target Identification

Using advanced analytics and pattern recognition, SAGEIQ identifies companies, technologies, and assets that align most closely with the defined strategic criteria.

​

The platform evaluates potential partners against a range of factors, including:

• therapeutic and scientific alignment
• portfolio fit and pipeline gaps
• development capabilities
• historical partnering behavior
• geographic presence and commercial reach

This stage generates a broad universe of potential partners or opportunities.

​

4. Strategic Qualification

The initial opportunity universe is then refined through Sage’s Partnering Precision™ methodology.

At this stage, Sage’s advisory team conducts deeper strategic qualification, assessing:

• strategic relevance
• transaction feasibility
• competitive positioning
• likelihood of engagement

​This process transforms the broad opportunity universe into a highly qualified and prioritized partner list.

​

5. Partner Engagement and Execution

Once priority targets have been identified, Sage supports the engagement and execution process through its global business development network.

This may include:

• preparation of strategic outreach materials
• targeted partner engagement
• management of partnering discussions
• transaction structuring support

​Through this process, SAGEIQ enables clients to move rapidly from opportunity discovery to active partnering discussions.

 

The Result

By combining AI-powered discovery with expert human judgment, SAGEIQ delivers:

• faster identification of relevant partners
• deeper strategic intelligence
• more efficient business development processes
• increased probability of successful transactions

semi-quantitative ranking of execution likelihood

SAGEIQ represents a new model for data-driven partnering and licensing in the life sciences industry.